Infectious Disease
Premier workflow solutions
Standardization and automation are prerequisites for reliable pathogen tests and bacterial tests used in molecular laboratories. Automated processing increases reproducibility, minimizes human error and delivers results you can trust. Our integrated systems using pathogen tests and viral load tests maximize your efficiency and optimize your workflows. Furthermore, our premier automated solutions deliver the flexibility and scalability your lab needs to adapt to changing testing demands.
閲覧 Infectious Disease
製品
Sort
12個の製品が見つかりました
QIAsymphony SP/AS Instruments
サンプル調製からアッセイセットアップまでの自動化ソリューション
QIAstat-Dx
For multiplex syndromic testing applications
artus SARS-CoV-2 Prep&Amp UM Kit
For fast and simplified SARS-CoV-2 detection in diagnostic applications
artus HBV PCR Kits CE
For quantitative detection of hepatitis B virus DNA using real-time PCR
artus Infl. A/B/H1 QS-RGQ Kit CE
For the separate qualitative detection and identification of influenza A and/or B virus RNA and influenza A-H1 Pandemic 2009 strain (H1pdm2009) in human nasal swabs.
artus Infl./H1 LC/RG RT-PCR Kit RUO
For detection of influenza A/B RNA and specific detection of influenza A (H1N1) RNA (pandemic 2009)
artus HAV TM RT-PCR Kit v2.0 RUO
For quantitative detection of hepatitis A virus RNA using real-time PCR
NeuMoDx blood borne virus assays
The NeuMoDx system and assays are intended for in vitro diagnostic use. Product availability may vary from country to country. Contact your country representative for further details.
IVD reagents and consumables for use in NeuMoDx instrument open mode
To support customers developing in-house assays using real-time PCR molecular testing
NeuMoDx Molecular System
For integrated easy-to-use workflows with a comprehensive menu that allows consolidation of infectious disease testing onto a single system
QIAstat-Dx research
For multiplex PCR syndromic applications
QuantiFERON SARS-CoV-2
For qualitative detection of IFN-gamma produced by CD4+ and CD8+ T cell responses to SARS-CoV-2 peptides